Cargando…

Salusin beta, atherosclerosis, and coronary slow flow

Detalles Bibliográficos
Autores principales:	Akıncı, Sinan, Çoner, Ali
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Kare Publishing 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7040877/ https://www.ncbi.nlm.nih.gov/pubmed/32011318 http://dx.doi.org/10.14744/AnatolJCardiol.2019.11680

Ejemplares similares

Relationship of serum salusin beta levels with coronary slow flow
por: Akyüz, Aydın, et al.
Publicado: (2019)

Measurement of salusin-ß without the addition of NP-40 or Tween-20 in coronary slow-flow phenomenon
por: Aydın, Suna, et al.
Publicado: (2020)

Salusin-β is superior to salusin-α as a marker for evaluating coronary atherosclerosis
por: Wang, Yuxue, et al.
Publicado: (2020)

Renal artery stenting of chronic kidney disease patient with resistant hypertension
por: Çoner, Ali, et al.
Publicado: (2016)

Coronary slow flow: Benign or ominous?
por: Anwar, Mohammed Omer, et al.
Publicado: (2016)

Left Atrial Function and Coronary Slow Flow: Is There Diastolic Dysfunction or Not?
por: Longobardo, Luca
Publicado: (2018)

Is the serum level of salusin-β associated with hypertension and atherosclerosis in the pediatric population?
por: Kołakowska, Urszula, et al.
Publicado: (2014)

Serum salusin-α and salusin-β levels in patients with psoriatic arthritis
por: Kobak, Senol, et al.
Publicado: (2022)

Interleukin-1 gene cluster polymorphisms associated with coronary slow flow phenomenon
por: Yasri, Sora, et al.
Publicado: (2018)

Restless leg syndrome and slow coronary flow. Is it inflammation or autonomic nervous system?
por: Tekin, Göknur
Publicado: (2015)

Platelet to lymphocyte ratio: a novel and simple predictor of slow coronary flow
por: Akboğa, Mehmet Kadri, et al.
Publicado: (2016)

Vitamin D and coronary atherosclerosis
por: Kim, Dae Jung
Publicado: (2017)

Slow Flow Phenomenon Impairs the Prognosis of Coronary Artery Ectasia as Well as Coronary Atherosclerosis
por: Kaplan, Mehmet, et al.
Publicado: (2021)

Reply on “Vitamin D and coronary atherosclerosis”
por: Lee, Ah-Young, et al.
Publicado: (2017)

Complete blood cell count components and coronary slow-flow phenomenon
por: Arjmand, Nasim, et al.
Publicado: (2016)

Brain, Liver, and Serum Salusin-alpha and -beta Alterations in Sprague-Dawley Rats with or without Metabolic Syndrome
por: Citil, Cihan, et al.
Publicado: (2014)

Hidden Coronary Atherosclerosis Assessment but Not Coronary Flow Reserve Helps to Explain the Slow Coronary Flow Phenomenon in Patients with Angiographically Normal Coronary Arteries
por: Caiati, Carlo, et al.
Publicado: (2022)

Salusin-β as a powerful endogenous antidipsogenic neuropeptide
por: Suzuki-Kemuriyama, Noriko, et al.
Publicado: (2016)

Coronary slow flow: Benign or ominous?
por: Sadr-Ameli, Mohammad Ali, et al.
Publicado: (2015)

Effects of Two Types of Moderate- and High-Intensity Interval Training on Serum Salusin-α and Salusin-β Levels and Lipid Profile in Women with Overweight/Obesity
por: Nazari, Maryam, et al.
Publicado: (2020)

Do spontaneous coronary artery dissections always need intervention in patients with no atherosclerosis?
por: Öztürk, Cengiz, et al.
Publicado: (2016)

Salusins: Potential Use as a Biomarker for Atherosclerotic Cardiovascular Diseases
por: Sato, Kengo, et al.
Publicado: (2013)

Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy
por: Zhao, Ming-Xia, et al.
Publicado: (2017)

A New Marker for Determining Cardiovascular Risk: Salusin Alpha
por: Yılmaz, Emre, et al.
Publicado: (2022)

Cardiac autonomic nervous dysfunction detected by both heart rate variability and heart rate turbulence in prediabetic patients with isolated impaired fasting glucose
por: Balcıoğlu, Akif Serhat, et al.
Publicado: (2016)

Salusin-β Not Salusin-α Promotes Vascular Inflammation in ApoE-Deficient Mice via the I-κBα/NF-κB Pathway
por: Zhou, Cheng-Hua, et al.
Publicado: (2014)

Salusin-β, but Not Salusin-α, Promotes Human Umbilical Vein Endothelial Cell Inflammation via the p38 MAPK/JNK-NF-κB Pathway
por: Zhou, Cheng-Hua, et al.
Publicado: (2014)

Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
por: Huang, Yi-Chun, et al.
Publicado: (2022)

Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
por: An, Jihyun, et al.
Publicado: (2022)

Identification and quantification of plasma free salusin-β, an endogenous parasympathomimetic peptide
por: Fujimoto, Kazumi, et al.
Publicado: (2017)

The Clinical Significance of Salusins in Systemic Sclerosis—A Cross-Sectional Study
por: Nowaczyk, Joanna, et al.
Publicado: (2023)

Epicardial adipose excision slows the progression of porcine coronary atherosclerosis
por: McKenney, Mikaela L, et al.
Publicado: (2014)

Rapid progression of atherosclerosis in a patient with acute coronary syndrome and ANCA-associated vasculitis: split or confluence?
por: LI, Ya-Chao, et al.
Publicado: (2022)

Fibrinogen and Atherosclerosis
por: Cerit, Levent
Publicado: (2017)

Transcriptional activity of tumor necrosis factor-alpha gene in peripheral blood mononuclear cells in patients with coronary slow flow
por: Rasmi, Yousef, et al.
Publicado: (2017)

Coronary Slow Flow Phenomenon Clinical Findings and Predictors
por: Sanati, Hamidreza, et al.
Publicado: (2016)

Atorvastatin improves coronary flow and endothelial function in patients with coronary slow flow
por: Niu, Hongmei, et al.
Publicado: (2018)

Circulating Levels of Human salusin-β,a Potent Hemodynamic and Atherogenesis Regulator
por: Fujimoto, Kazumi, et al.
Publicado: (2013)

Overexpression of Salusin-α Inhibits Vascular Intimal Hyperplasia in an Atherosclerotic Rabbit Model
por: Qian, Kun, et al.
Publicado: (2018)

Identification of the salusin-β receptor using proteoliposomes embedded with endogenous membrane proteins
por: Shichiri, Masayoshi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9dqnc1qrnckgku8hmj4opat157